Lipocine (LPCN) Stock Chart & Stock Price History $6.08 +0.54 (+9.75%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lipocine Stock Price Performance5 Day Performance+9.55%1 Month Performance+43.06%3 Month Performance+22.58%6 Month Performance+29.36%Year-To-Date Performance+117.92%1 Year Performance+135.66% Receive LPCN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. LPCN Stock Chart for Saturday, November, 2, 2024 LPCN Chart by TradingView Lipocine Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$5.54$6.08+9.75%$6.13$5.5471,201 shs$32.53 million10/31/2024$5.42$5.54+2.21%$5.68$5.3919,166 shs$29.63 million10/30/2024$5.57$5.42-2.69%$5.64$5.363,971 shs$28.99 million10/29/2024$5.55$5.57+0.36%$5.61$5.338,687 shs$29.79 million10/28/2024$5.77$5.55-3.81%$5.87$5.2740,291 shs$29.68 million10/25/2024$5.72$5.77+0.87%$5.79$5.4915,459 shs$30.87 million Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$5.47$5.72+4.57%$5.87$5.5415,447 shs$30.59 million10/23/2024$5.40$5.47+1.30%$5.50$5.1333,584 shs$29.25 million10/22/2024$5.56$5.40-2.88%$5.52$5.3011,534 shs$28.88 million10/21/2024$5.23$5.56+6.31%$5.85$5.0675,003 shs$29.74 million10/18/2024$5.04$5.23+3.77%$5.32$5.0315,176 shs$27.97 million10/17/2024$5.08$5.04-0.79%$5.08$4.938,885 shs$26.95 million10/16/2024$5.08$5.08$5.20$4.909,824 shs$27.17 million10/15/2024$5.11$5.08-0.49%$5.30$5.0013,893 shs$27.17 million10/14/2024$5.14$5.11-0.68%$5.14$5.0110,188 shs$27.30 million10/11/2024$5.20$5.14-1.15%$5.33$4.9726,705 shs$27.50 million10/10/2024$5.17$5.20+0.58%$5.39$4.9135,246 shs$27.81 million10/09/2024$5.30$5.17-2.45%$5.35$4.8931,059 shs$27.65 million10/08/2024$4.99$5.30+6.21%$5.49$4.9041,205 shs$28.34 million10/07/2024$4.66$4.99+7.08%$5.20$4.5921,046 shs$26.69 million10/04/2024$4.48$4.66+4.02%$5.00$4.5030,285 shs$24.92 million10/03/2024$4.25$4.48+5.41%$4.63$4.406,224 shs$23.96 million10/02/2024$4.33$4.25-1.85%$4.50$4.2420,830 shs$22.73 million10/01/2024$4.49$4.33-3.56%$4.62$4.0124,023 shs$23.16 million09/30/2024$4.44$4.49+1.13%$4.53$4.3116,084 shs$24.01 million09/27/2024$4.64$4.44-4.31%$4.79$4.3522,754 shs$23.75 million09/26/2024$4.74$4.64-2.11%$4.88$4.5011,293 shs$24.82 million09/25/2024$4.55$4.74+4.18%$4.96$4.5012,011 shs$25.36 million09/24/2024$4.54$4.55+0.22%$4.84$4.5035,373 shs$24.33 million09/23/2024$4.84$4.54-6.20%$4.87$4.4022,421 shs$24.28 million09/20/2024$4.77$4.84+1.47%$5.12$4.6117,556 shs$25.88 million09/19/2024$5.01$4.77-4.79%$5.29$4.7455,261 shs$25.51 million09/18/2024$4.83$5.01+3.73%$5.56$4.8489,165 shs$26.79 million09/17/2024$4.75$4.83+1.68%$5.62$4.59262,428 shs$25.83 million09/16/2024$4.61$4.75+3.04%$4.83$4.4339,782 shs$25.41 million09/13/2024$4.08$4.61+12.99%$4.84$4.0865,498 shs$24.66 million09/12/2024$3.92$4.08+4.08%$4.39$3.8726,615 shs$21.82 million09/11/2024$3.98$3.92-1.51%$4.20$3.8516,064 shs$20.97 million09/10/2024$3.74$3.98+6.42%$4.20$3.7450,638 shs$21.29 million09/09/2024$3.66$3.74+2.19%$3.74$3.5816,255 shs$20.01 millionTrue paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.09/06/2024$3.74$3.66-2.14%$3.74$3.5313,167 shs$19.57 million09/05/2024$3.72$3.74+0.54%$3.74$3.5924,120 shs$20.00 million09/04/2024$3.65$3.72+1.92%$3.72$3.5514,845 shs$19.90 million09/03/2024$3.67$3.65-0.54%$3.65$3.5714,340 shs$19.52 million09/02/2024$3.67$3.67$3.69$3.524,800 shs$19.63 million08/30/2024$3.59$3.67+2.23%$3.69$3.524,876 shs$19.63 million08/29/2024$3.70$3.59-2.97%$3.72$3.5020,535 shs$19.20 million08/28/2024$3.52$3.70+5.11%$3.71$3.5012,050 shs$19.79 million08/27/2024$3.63$3.52-3.03%$3.69$3.5210,903 shs$18.83 million08/26/2024$3.67$3.63-1.09%$3.72$3.5525,889 shs$19.41 million08/23/2024$3.71$3.67-1.08%$3.72$3.6611,902 shs$19.63 million08/22/2024$3.58$3.71+3.63%$3.73$3.604,930 shs$19.84 million08/21/2024$3.64$3.58-1.65%$3.71$3.5522,063 shs$19.15 million08/20/2024$3.71$3.64-1.89%$3.70$3.5714,194 shs$19.47 million08/19/2024$3.70$3.71+0.27%$3.82$3.5729,480 shs$19.84 million08/16/2024$3.66$3.70+1.09%$3.83$3.5845,090 shs$19.79 million08/15/2024$3.78$3.66-3.17%$3.84$3.6628,396 shs$19.57 million08/14/2024$3.80$3.78-0.53%$3.90$3.7712,606 shs$20.22 million08/13/2024$4.01$3.80-5.24%$4.01$3.7225,881 shs$20.32 million08/12/2024$4.41$4.01-9.07%$4.38$3.7154,793 shs$21.45 million08/09/2024$4.39$4.41+0.46%$4.73$3.9240,619 shs$23.59 million08/08/2024$5.04$4.39-12.90%$5.43$4.25110,604 shs$23.48 million08/07/2024$5.12$5.04-1.56%$5.92$4.95107,182 shs$26.95 million08/06/2024$4.98$5.12+2.81%$5.13$4.9615,554 shs$27.39 million08/05/2024$4.96$4.98+0.40%$5.11$4.6721,241 shs$26.64 million08/02/2024$5.08$4.96-2.36%$5.17$4.8513,800 shs$26.54 million08/01/2024$5.21$5.08-2.50%$5.27$4.969,566 shs$27.18 million Related Companies TNXP Stock Price Chart LTRN Stock Price Chart PDSB Stock Price Chart HOWL Stock Price Chart LPTX Stock Price Chart IMUX Stock Price Chart MCRB Stock Price Chart IPSC Stock Price Chart DERM Stock Price Chart OPTN Stock Price Chart Receive LPCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LPCN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LPCN Stock Alerts